Requirements for diploid allogenic cell lines used for regenerative medicine

Cell transplantation becomes a mode of correcting the functional failure of organs and tissues in injury and a number of diseases. The paper considers the issues concerning the biological safety of therapy with differential cells: in vitro cultured fibroblasts. The Russian line M-22 derived from the...

Full description

Bibliographic Details
Main Authors: O. I. Konyushko, B. V. Khvatov, S. V. Smirnov, V. S. Bocharova
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/252
_version_ 1826564629190410240
author O. I. Konyushko
B. V. Khvatov
S. V. Smirnov
V. S. Bocharova
author_facet O. I. Konyushko
B. V. Khvatov
S. V. Smirnov
V. S. Bocharova
author_sort O. I. Konyushko
collection DOAJ
description Cell transplantation becomes a mode of correcting the functional failure of organs and tissues in injury and a number of diseases. The paper considers the issues concerning the biological safety of therapy with differential cells: in vitro cultured fibroblasts. The Russian line M-22 derived from the skin and muscle of diploid human embryonic cells has persisted just for more than 40 years and successfully used to treat patients with severe burns.
first_indexed 2024-03-12T04:56:06Z
format Article
id doaj.art-bd4cc2db375d4df897ca8226e755b28a
institution Directory Open Access Journal
issn 2074-0506
2542-0909
language English
last_indexed 2025-03-14T10:22:54Z
publishDate 2018-08-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj.art-bd4cc2db375d4df897ca8226e755b28a2025-03-02T11:07:32ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092018-08-0102313410.23873/2074-0506-2009-0-2-31-34241Requirements for diploid allogenic cell lines used for regenerative medicineO. I. Konyushko0B. V. Khvatov1S. V. Smirnov2V. S. Bocharova3N.V. Sklifosovsky Research Institute of Emergency CareN.V. Sklifosovsky Research Institute of Emergency CareN.V. Sklifosovsky Research Institute of Emergency CareN.V. Sklifosovsky Research Institute of Emergency CareCell transplantation becomes a mode of correcting the functional failure of organs and tissues in injury and a number of diseases. The paper considers the issues concerning the biological safety of therapy with differential cells: in vitro cultured fibroblasts. The Russian line M-22 derived from the skin and muscle of diploid human embryonic cells has persisted just for more than 40 years and successfully used to treat patients with severe burns.https://www.jtransplantologiya.ru/jour/article/view/252stem cell transplantationbiological safetydiploid cell line
spellingShingle O. I. Konyushko
B. V. Khvatov
S. V. Smirnov
V. S. Bocharova
Requirements for diploid allogenic cell lines used for regenerative medicine
Трансплантология (Москва)
stem cell transplantation
biological safety
diploid cell line
title Requirements for diploid allogenic cell lines used for regenerative medicine
title_full Requirements for diploid allogenic cell lines used for regenerative medicine
title_fullStr Requirements for diploid allogenic cell lines used for regenerative medicine
title_full_unstemmed Requirements for diploid allogenic cell lines used for regenerative medicine
title_short Requirements for diploid allogenic cell lines used for regenerative medicine
title_sort requirements for diploid allogenic cell lines used for regenerative medicine
topic stem cell transplantation
biological safety
diploid cell line
url https://www.jtransplantologiya.ru/jour/article/view/252
work_keys_str_mv AT oikonyushko requirementsfordiploidallogeniccelllinesusedforregenerativemedicine
AT bvkhvatov requirementsfordiploidallogeniccelllinesusedforregenerativemedicine
AT svsmirnov requirementsfordiploidallogeniccelllinesusedforregenerativemedicine
AT vsbocharova requirementsfordiploidallogeniccelllinesusedforregenerativemedicine